Top News

Jul 12, 2018
By BioPharm International Editors
The agency is releasing six new draft guidances to provide a regulatory framework for handling gene therapies.
Jul 11, 2018
By BioPharm International Editors
Pfizer creates separate business units for innovator medicines, generic drugs, and consumer products.
Jul 11, 2018
By BioPharm International Editors
The company has received clearance from the United States Federal Trade Commission for the proposed acquisition of Shire, a deal valued at $62 billion.
Jul 03, 2018
By BioPharm International Editors
The pharma major intends to spinoff Alcon as a stand-alone eye-care devices company.
Jul 03, 2018
By BioPharm International Editors
Biogen will pay Samsung BioLogics approximately $700 million to increase its stake in Samsung Bioepis to approximately 49.9%.
Jun 26, 2018
By BioPharm International Editors
Strategic restructuring is designed to position GE Healthcare as a pure-play healthcare company.
Jun 25, 2018
By BioPharm International Editors
GW Research’s Epidiolex, which treats two forms of epilepsy, receives FDA’s approval; spurs FDA reminders about unapproved products.
Jun 20, 2018
By BioPharm International Editors
The acquisition is expected to strengthen Roche’s personalized healthcare strategy.
Jun 20, 2018
By BioPharm International Editors
The acquisition is expected to strengthen Sanofi’s R&D strategy with Ablynx’s nanobody technology platform.
Jun 13, 2018
By BioPharm International Editors
Bayer completed its acquisition of Monsanto, the largest in Bayer’s history.
native1_300x100
lorem ipsum